Detalhe da pesquisa
1.
Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia.
Ann Hematol
; 99(7): 1551-1560, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32504186
2.
A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy.
Haematologica
; 97(3): 393-401, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22058219